INTERNATIONAL PATENT: ALCHEMAB THERAPEUTICS LTD FILES APPLICATION FOR "ANTIBODY ENGINEERING WITH CONSTRAINED MACHINE LEARNING"

GENEVA, Oct. 4 -- ALCHEMAB THERAPEUTICS LTD (East Side Office 1.02Kings CrossLondon N1C 4AX) filed a patent application (PCT/EP2025/058186) for "ANTIBODY ENGINEERING WITH CONSTRAINED MACHINE LEARNING" on Mar 25, 2025. With publication no. WO/2025/202233, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEEM, Jinwoo (c/o Alchemab Therapeutics LtdEast Side Office 1.02Kings CrossLondon N1C 4AX), GALSON, Jacob Daniel (c/o Alchemab Therapeutics LtdEast Side Office 1.02Kings CrossLondon N1C 4AX), BARTON, Justin (c/o Alchemab The...